PMID: 3753814Jan 1, 1986Paper

Goitre size and outcome of medical treatment of Graves' disease

Acta Endocrinologica
P LaurbergJ Weeke

Abstract

One hundred and twenty-four patients with newly diagnosed hyperthyroidism received a combined thionamid-thyroxine medical therapy for approximately 2 years. According to the estimated goitre size before therapy and the type of goitre the patients were divided into 4 groups: Graves' disease no goitre (n = 19), Graves' disease small goitre (n = 57), Graves' disease medium or large goitre (n = 23), multinodular goitre (n = 25). The median follow-up period after cessation of medication was 64 (range 11-141) months. The remission rates in the different groups during follow-up were calculated using life table analysis. Graves' patients with no goitre or a small goitre had a significantly better outcome (remission % after 5 years 82.5 +/- 15.4 (SE) and 71.5 +/- 7.8, respectively) than Graves' patients with a medium size or large goitre (remission % after 5 years 37.0 +/- 11.1)(P less than 0.025). Most patients with multinodular goitre had a relapse within the first year after stop of medication (remission % after 5 years 15.5 +/- 10.1). Hence patients with Graves' disease having a small thyroid gland should be treated medically while surgery or radioiodine may be a more reasonable choice in Graves' patients with medium size or large g...Continue Reading

Citations

Jul 11, 2001·Endocrinology and Metabolism Clinics of North America·L Hegedüs
Apr 16, 1998·Endocrinology and Metabolism Clinics of North America·D S Cooper
Apr 9, 1998·Baillière's Clinical Endocrinology and Metabolism·A Toft
May 7, 1988·British Medical Journal·T W de BruinD van der Heide
Oct 27, 2016·European Journal of Endocrinology·Tristan StrujaPhilipp Schuetz
Jan 25, 2005·Drugs & Aging·Peter LaurbergAllan Carlé
Sep 29, 2005·Thyroid : Official Journal of the American Thyroid Association·Beate QuadbeckUNKNOWN Basedow Study Group
Jan 1, 2006·Expert Review of Endocrinology & Metabolism·Peter LaurbergJesper Karmisholt
Jun 1, 1997·Thyroid : Official Journal of the American Thyroid Association·P VittiA Pinchera
Mar 24, 1998·Thyroid : Official Journal of the American Thyroid Association·V MichelangeliP Colman
Apr 23, 2011·Thyroid : Official Journal of the American Thyroid Association·Rebecca S Bahn ChairUNKNOWN American Association of Clinical Endocrinologists
Aug 13, 2011·Thyroid : Official Journal of the American Thyroid Association·Peter LaurbergInge Bülow Pedersen
Mar 29, 2019·Endocrine Journal·Sachiko BandaiTakanari Kitazono
Aug 12, 2014·Current Opinion in Endocrinology, Diabetes, and Obesity·Peter LaurbergStine Linding Andersen
Dec 19, 2002·Thyroid : Official Journal of the American Thyroid Association·Jacques Orgiazzi, Anne-Marie Madec
Mar 17, 2000·The Journal of Clinical Endocrinology and Metabolism·A AllahabadiaJ A Franklyn
Dec 1, 1992·Journal of Endocrinological Investigation·M J van SoestbergenA D Graafland
Aug 16, 2016·Thyroid : Official Journal of the American Thyroid Association·Douglas S RossMartin A Walter
Jan 1, 1987·Langenbecks Archiv für Chirurgie·H DralleR D Hesch
Mar 18, 2006·Arquivos brasileiros de endocrinologia e metabologia·Maria Claudia PeixotoMário Vaisman
Dec 23, 1998·Clinical Endocrinology·N J Leech, C M Dayan
Mar 18, 2004·European Journal of Clinical Investigation·E OrunesuG S Mela
Mar 5, 2021·Thyroid Research·Yotsapon ThewjitcharoenThep Himathongkam
Jun 28, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Rebecca S BahnUNKNOWN American Association of Clinical Endocrinologists

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.